Company

ProImmune’s mission is to help its customers understand and manage adaptive immune responses. We offer unique immune monitoring solutions for clinical trials and immunology research, including tracking antigen-specific immune responses with state of the art ELISpot and flow cytometric analysis techniques. We are committed to helping our customers take their studies to success through product innovation, responsive service and focused application support.

Directors and Management

Dr Nikolai Schwabe
Founder, Chief Executive Officer

Nik's responsibility is the day-to-day management of the company's business. Prior to founding ProImmune, Nik was responsible for Business Development and Intellectual Property at Bookham Technology plc, a fibre-optic components maker based in Abingdon, Oxon. Before joining Bookham he worked as a financial analyst at Salomon Brothers International in London, advising clients on financial portfolio strategies. Nik holds a D.Phil. in Theoretical Physics from Oxford University.

Dr Linda Tan
Founder, President & Chief Operating Officer

Linda's responsibility is the day-to-day management of ProImmune's operations, including its Research and Development activities. Before founding ProImmune, Linda worked at the Institute of Molecular Medicine at Oxford in the laboratory of Prof. Andrew McMichael where her work focused on T cell immunology and the MHC pathway. Linda holds a D.Phil. in Molecular Immunology and a B.A. in Biochemistry, both from Oxford University.